MICHELLE CHANIN: Open Payments
NPI 1942836895 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 22 payments from 6 companies in 2025. Trend: 2023 $373 · 2024 $267 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 13 | $266 |
| Phathom Pharmaceuticals, Inc. | 1 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $97 |
| Janssen Biotech, Inc. | 2 | $56 |
| Gilead Sciences, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: REZDIFFRA, VOQUEZNA, ENTYVIO, TREMFYA, XIFAXAN.
Industry payments across NY — which companies pay providers there.
